High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer

Cancer

Volumn 116, Issue 21, 2010, Pages 5030-5037

  Everitt, Sarah ^a,b   Herschtal, Alan ^a   Callahan, Jason ^a   Plumridge, Nikki ^a,c   Ball, David ^a,c   Kron, Tomas ^a,b   Schneider Kolsky, Michal ^b   Binns, David ^a   Hicks, Rodney J ^a,c   MacManus, Michael ^a,c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Disease progression; Fluorodeoxyglucose positron emission tomography computed tomography; Lung cancer; Radiotherapy; Tumor volume doubling time; Waiting time

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; DISEASE COURSE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR GROWTH; WHOLE BODY CT; WHOLE BODY PET;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 78249271742     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25392     Document Type: Article

References (28)

1. Bozcuk H, Martin C,. Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre. Lung Cancer. 2001; 34: 243 -252.
2. Eastham DV, Weerasuriya D, Wakelee H, et al. Quantification of progression of non-small cell lung cancer in the interval between diagnostic and radiotherapy treatment planning PET scans. Int J Radiat Oncol Biol Phys. 2007; 69 (3 suppl 1): S520 -S521.
3. MacManus M, Bayne M, Everitt S, Ball D, Hicks R,. High incidence of progression of non-small cell lung cancer between staging and treatment-planning FDG-PET/CT scans in candidates for radical radiation therapy [abstract]. Int J Radiat Oncol Biol Phys. 2006; 66 (3 suppl 1): S463. Abstract 2457.
4. O'Rourke N, Edwards R,. Lung cancer treatment waiting times and tumour growth. Clin Oncol (R Coll Radiol). 2000; 12: 141 -144.
5. Tann M, Sandrasegaran K, Winer-Muram HT, Jennings SG, Welling ME, Fletcher JW,. Can FDG-PET be used to predict growth of stage I lung cancer? Clin Radiol. 2008; 63: 856 -863.
6. Vinod S, Kaplan A,. Growth of non-small cell lung cancer from diagnosis to radiotherapy treatment [abstract]. Lung Cancer. 2005; 49 (suppl 2): S315. Abstract P-747.
7. Wang L, Correa CR, Hayman JA, et al. Time to treatment in patients with stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2009; 74: 790 -795.
8. Pieterman RM, van Putten JWG, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med. 2000; 343: 254 -261.
9. Silvestri GA, Hoffman B, Reed CE,. One from column A: choosing between CT, positron emission tomography, endoscopic ultrasound with fine-needle aspiration, transbronchial needle aspiration, thoracoscopy, mediastinoscopy, and mediastinotomy for staging lung cancer. Chest. 2003; 123: 333 -335.
10. Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ,. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol. 2008; 87: 3 -16.
11. Friberg S, Mattson S,. On the growth rates of human malignant tumors: implications for medical decision making. J Surg Oncol. 1997; 65: 284 -297.
12. National Health and Medical Research Council. Clinical Practice Guidelines for the Prevention, Diagnosis and Management of Lung Cancer. Canberra, Australia: 2004.
13. Salomaa ER, Sallinen S, Hiekkanen H, Liippo K,. Delays in the diagnosis and treatment of lung cancer. Chest. 2005; 128: 2282 -2288.
14. MacManus M, Hicks RJ,. The use of positron emission tomography (PET) in the staging/evaluation, treatment, and follow-up of patients with lung cancer: a critical review. Int J Radiat Oncol Biol Phys. 2008; 72: 1298 -1306.
15. Toloza EM, Harpole L, McCrory DC,. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest. 2003; 123 (1 suppl): 137S -146S.
16. Greene FL, Page, DL, Fleming ID,. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
17. Mountain CF,. Revisions in the International System for Staging Lung Cancer. Chest. 1997; 111: 1710 -1717.
18. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumors. 6th ed. New York, NY: John Wiley & Sons; 2002.
19. Nahmias C, Wahl LM,. Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors. J Nucl Med. 2008; 49: 1804 -1808.
20. Bayne M, MacManus M, Hicks R, Leong T, Peters L, Ball D,. Can a mathematical formula help define a radiation target volume using positron emission tomography? In regard to Black, et al. (Int J Radiat Oncol Biol Phys. 2004;60:1272-1282). Int J Radiat Oncol Biol Phys. 2005; 62: 299 -300.
21. Jennings SG, Winer-Muram HT, Tann M, Ying J, Dowdeswell I,. Distribution of stage I lung cancer growth rates determined with serial volumetric CT measurements. Radiology. 2006; 241: 554 -563.
22. Norton L,. A Gompertzian model of human breast cancer growth. Cancer Res. 1988; 48 (24 pt 1): 7067 -7071.
23. Miller CW,. Growth characteristics of pulmonary metastases from osteosarcoma. Clin Orthop Relat Res. 1976;(116): 70 -75.
24. Blomqvist C, Wiklund T, Tarkkanen M, Elomaa I, Virolainen M,. Measurement of growth rate of lung metastases in 21 patients with bone or soft-tissue sarcoma. Br J Cancer. 1993; 68: 414 -417.
25. Clavo AC, Brown RS, Wahl RL,. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med. 1995; 36: 1625 -1632.
26. Ball D, Bryan B, Peter G, et al. Is tumor volume an independent prognostic factor in non-smallcell lung cancer (NSCLC) treated with radical radiotherapy? Interim analysis of the Trans-Tasman Radiation Oncology Group (TROG) database 99-05 [abstract]. Lung Cancer. 2005; 49 (suppl 2): S208. Abstract P-351.
27. Joint Council for Clinical Oncology. Reducing Delays in Cancer Treatment: Some Targets. London, UK: Royal College of Physicians; 1993.
28. Mackillop WJ, Bates JH, O'Sullivan B, Withers HR,. The effect of delay in treatment on local control by radiotherapy. Int J Radiat Oncol Biol Phys. 1996; 34: 243 -250.